chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Diarrhoea, Fatigue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite) and DIARRHEA (diarrhea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 13-Nov-2020 and COVID-19 on 02-Apr-2021. Concurrent medical conditions included Food allergy (Red Dye). Concomitant products included IBUPROFEN for an unknown indication. On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, the patient experienced PYREXIA (fever of 102 for 2 days). On an unknown date, the patient experienced ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite), DIARRHOEA (diarrhea), CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous). On 31-May-2021, PYREXIA (fever of 102 for 2 days) had resolved. At the time of the report, ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite), DIARRHOEA (diarrhea), CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-May-2021, Body temperature: 102 (High) Fever. On 29-May-2021, SARS-CoV-2 antibody test: positive (Positive) Had been diagnosed with COVID twice. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Reporter information, Symptoms similar to COVID, 102 degree fever were updated. On 29-Jul-2021: Follow up received 29-JUL-2021.  Historical Conditions of Covid-19 updated with onset dates. Allergy to red dye added. Patient height and weight added. Action Taken updated.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Lethargy, Malaise, Nausea, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite) and DIARRHEA (diarrhea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 13-Nov-2020 and COVID-19 on 02-Apr-2021. Concurrent medical conditions included Food allergy (Red Dye). Concomitant products included IBUPROFEN for an unknown indication. On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, the patient experienced PYREXIA (fever of 102 for 2 days). On an unknown date, the patient experienced ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite), DIARRHOEA (diarrhea), CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous). On 31-May-2021, PYREXIA (fever of 102 for 2 days) had resolved. At the time of the report, ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite), DIARRHOEA (diarrhea), CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-May-2021, Body temperature: 102 (High) Fever. On 29-May-2021, SARS-CoV-2 antibody test: positive (Positive) Had been diagnosed with COVID twice. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Reporter information, Symptoms similar to COVID, 102 degree fever were updated. On 29-Jul-2021: Follow up received 29-JUL-2021.  Historical Conditions of Covid-19 updated with onset dates. Allergy to red dye added. Patient height and weight added. Action Taken updated.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite) and DIARRHEA (diarrhea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 13-Nov-2020 and COVID-19 on 02-Apr-2021. Concurrent medical conditions included Food allergy (Red Dye). Concomitant products included IBUPROFEN for an unknown indication. On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, the patient experienced PYREXIA (fever of 102 for 2 days). On an unknown date, the patient experienced ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite), DIARRHOEA (diarrhea), CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous). On 31-May-2021, PYREXIA (fever of 102 for 2 days) had resolved. At the time of the report, ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite), DIARRHOEA (diarrhea), CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-May-2021, Body temperature: 102 (High) Fever. On 29-May-2021, SARS-CoV-2 antibody test: positive (Positive) Had been diagnosed with COVID twice. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Reporter information, Symptoms similar to COVID, 102 degree fever were updated. On 29-Jul-2021: Follow up received 29-JUL-2021.  Historical Conditions of Covid-19 updated with onset dates. Allergy to red dye added. Patient height and weight added. Action Taken updated.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: sore arm; overnight headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) and HEADACHE (overnight headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm) and HEADACHE (overnight headache). At the time of the report, MYALGIA (sore arm) and HEADACHE (overnight headache) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed his second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed his second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed his second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed his second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test
Clinical narrative: Patient was tested positive for COVID infection in February; We have a patient who received 1st dose of Moderna back in January ( patient has not receive a second dose and it cross passed 36 days); This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Patient was tested positive for COVID infection in February) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (We have a patient who received 1st dose of Moderna back in January ( patient has not receive a second dose and it cross passed 36 days)) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (We have a patient who received 1st dose of Moderna back in January ( patient has not receive a second dose and it cross passed 36 days)). On 12-Feb-2021, the patient experienced COVID-19 (Patient was tested positive for COVID infection in February). On 29-Jan-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (We have a patient who received 1st dose of Moderna back in January ( patient has not receive a second dose and it cross passed 36 days)) had resolved. At the time of the report, COVID-19 (Patient was tested positive for COVID infection in February) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, SARS-CoV-2 test: positive (Positive) Tested positive with COVID Infection on 12-Feb-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter was a health care professional and was reporting on behalf of a patient who received first dose of Moderna COVID-19 Vaccine and after patient's first dose, the patient was tested positive with COVID Infection on 12-Feb-2021.   Reportedly, the patient received antibody infusion at around 16-Feb-2021 or 17-Feb-2021. According to the reporter, the patient's doctor suggested to wait for 90 days from the date of antibody infusion to receive a vaccine and also suggested to get Janssen vaccine.   No Concomitant product use was reported.  Treatment information provided included antibody infusion.
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Pyrexia, Thinking abnormal, Vaccination site pain, Vomiting
Clinical narrative: Hard time thinking; Hard time standing; Throwing up; Low grade fever; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of THINKING ABNORMAL (Hard time thinking), DYSSTASIA (Hard time standing), VOMITING (Throwing up), PYREXIA (Low grade fever) and VACCINATION SITE PAIN (soreness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 040B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DROSPIRENONE;ETHINYLESTRADIOL for Birth control, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced THINKING ABNORMAL (Hard time thinking), DYSSTASIA (Hard time standing), VOMITING (Throwing up), PYREXIA (Low grade fever) and VACCINATION SITE PAIN (soreness at injection site). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 UNK. At the time of the report, THINKING ABNORMAL (Hard time thinking), DYSSTASIA (Hard time standing), VOMITING (Throwing up), PYREXIA (Low grade fever) and VACCINATION SITE PAIN (soreness at injection site) had resolved.            Concomitant medication taken by the patient included Anti-inflammatory topical gel, supplements.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Feeling abnormal, Headache
Clinical narrative: Fatigue; Body ache; mild fever; sore throat; joints hurt; headache; don't feel good; don't have energy; delayed second dose >42 days; This spontaneous case was reported by a patient and describes the occurrence of OFF LABEL USE (delayed second dose >42 days), OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (don't feel good), ASTHENIA (don't have energy) and ARTHRALGIA (joints hurt) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia. Concurrent medical conditions included Hypoglycemia and Fibromyalgia. Concomitant products included DULOXETINE, METHOCARBAMOL, AMITRIPTYLINE and GABAPENTIN for Fibromyalgia, VERAPAMIL for Hypoglycemia.    On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced OFF LABEL USE (delayed second dose >42 days). 01-Jun-2021, the patient experienced FEELING ABNORMAL (don't feel good) and ASTHENIA (don't have energy). On 02-Jun-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), ARTHRALGIA (joints hurt), HEADACHE (headache) and PYREXIA (mild fever). On an unknown date, the patient experienced FATIGUE (Fatigue) and MYALGIA (Body ache). The patient was treated with PREDNISONE for Pneumonia, at a dose of 1 dosage form. At the time of the report, OFF LABEL USE (delayed second dose >42 days), OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (don't feel good), ASTHENIA (don't have energy), ARTHRALGIA (joints hurt), HEADACHE (headache), FATIGUE (Fatigue), MYALGIA (Body ache) and PYREXIA (mild fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The other concomitant medication provided was Epi pen, Glucagon shot, Rescue inhaler and Air duo Inhaler.       Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Non significant Follow appended for document attachment
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Off label use, Oropharyngeal pain, Pyrexia
Clinical narrative: Fatigue; Body ache; mild fever; sore throat; joints hurt; headache; don't feel good; don't have energy; delayed second dose >42 days; This spontaneous case was reported by a patient and describes the occurrence of OFF LABEL USE (delayed second dose >42 days), OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (don't feel good), ASTHENIA (don't have energy) and ARTHRALGIA (joints hurt) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia. Concurrent medical conditions included Hypoglycemia and Fibromyalgia. Concomitant products included DULOXETINE, METHOCARBAMOL, AMITRIPTYLINE and GABAPENTIN for Fibromyalgia, VERAPAMIL for Hypoglycemia.    On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced OFF LABEL USE (delayed second dose >42 days). 01-Jun-2021, the patient experienced FEELING ABNORMAL (don't feel good) and ASTHENIA (don't have energy). On 02-Jun-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), ARTHRALGIA (joints hurt), HEADACHE (headache) and PYREXIA (mild fever). On an unknown date, the patient experienced FATIGUE (Fatigue) and MYALGIA (Body ache). The patient was treated with PREDNISONE for Pneumonia, at a dose of 1 dosage form. At the time of the report, OFF LABEL USE (delayed second dose >42 days), OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (don't feel good), ASTHENIA (don't have energy), ARTHRALGIA (joints hurt), HEADACHE (headache), FATIGUE (Fatigue), MYALGIA (Body ache) and PYREXIA (mild fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The other concomitant medication provided was Epi pen, Glucagon shot, Rescue inhaler and Air duo Inhaler.       Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Non significant Follow appended for document attachment
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Nasopharyngitis, Sneezing
Clinical narrative: Coughing; Sneezing; Head cold; Headache; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (Coughing), SNEEZING (Sneezing), NASOPHARYNGITIS (Head cold), HEADACHE (Headache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced COUGH (Coughing), SNEEZING (Sneezing), NASOPHARYNGITIS (Head cold), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with AZITHROMYCIN (Z-PAK) at an unspecified dose and frequency. At the time of the report, COUGH (Coughing), SNEEZING (Sneezing), NASOPHARYNGITIS (Head cold), HEADACHE (Headache) and CHILLS (Chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received their first dose of Moderna vaccine and on 26-May-2021, the patient had coughing, sneezing, headache, chills, and a head cold. On 30-May-2021, the patient visited the emergency room walk-in clinic where a Health care professional gave the patient a Z-pack of antibiotics. On the next day, the patient felt better but the symptoms were still present at the time of reporting.  No Concomitant product use was reported.
Sex: U
Vaccine: COVID19
Symptoms: Blepharospasm
Clinical narrative: eye twitching; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BLEPHAROSPASM (eye twitching) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLEPHAROSPASM (eye twitching). At the time of the report, BLEPHAROSPASM (eye twitching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Joint range of motion decreased, Myalgia, Pain in extremity
Clinical narrative: dizziness that at times felt like she was going to faint; cannot use her left arm to do certain things; pain in her arm goes all the way down to her hand; itch at injection site; arm is still hurting, arm hurts more while she drives, pain in her arm goes all the way down to her hand; fever; throwing up; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness that at times felt like she was going to faint), JOINT RANGE OF MOTION DECREASED (cannot use her left arm to do certain things), PAIN IN EXTREMITY (pain in her arm goes all the way down to her hand), VACCINATION SITE PRURITUS (itch at injection site) and MYALGIA (arm is still hurting, arm hurts more while she drives, pain in her arm goes all the way down to her hand) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-May-2021, the patient experienced DIZZINESS (dizziness that at times felt like she was going to faint), JOINT RANGE OF MOTION DECREASED (cannot use her left arm to do certain things), PAIN IN EXTREMITY (pain in her arm goes all the way down to her hand), VACCINATION SITE PRURITUS (itch at injection site), MYALGIA (arm is still hurting, arm hurts more while she drives, pain in her arm goes all the way down to her hand), PYREXIA (fever), VOMITING (throwing up) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness that at times felt like she was going to faint), JOINT RANGE OF MOTION DECREASED (cannot use her left arm to do certain things), PAIN IN EXTREMITY (pain in her arm goes all the way down to her hand), VACCINATION SITE PRURITUS (itch at injection site), MYALGIA (arm is still hurting, arm hurts more while she drives, pain in her arm goes all the way down to her hand), PYREXIA (fever), VOMITING (throwing up) and HEADACHE (headache) outcome was unknown.            No concomitant medication was provided.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pruritus, Vomiting
Clinical narrative: dizziness that at times felt like she was going to faint; cannot use her left arm to do certain things; pain in her arm goes all the way down to her hand; itch at injection site; arm is still hurting, arm hurts more while she drives, pain in her arm goes all the way down to her hand; fever; throwing up; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness that at times felt like she was going to faint), JOINT RANGE OF MOTION DECREASED (cannot use her left arm to do certain things), PAIN IN EXTREMITY (pain in her arm goes all the way down to her hand), VACCINATION SITE PRURITUS (itch at injection site) and MYALGIA (arm is still hurting, arm hurts more while she drives, pain in her arm goes all the way down to her hand) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-May-2021, the patient experienced DIZZINESS (dizziness that at times felt like she was going to faint), JOINT RANGE OF MOTION DECREASED (cannot use her left arm to do certain things), PAIN IN EXTREMITY (pain in her arm goes all the way down to her hand), VACCINATION SITE PRURITUS (itch at injection site), MYALGIA (arm is still hurting, arm hurts more while she drives, pain in her arm goes all the way down to her hand), PYREXIA (fever), VOMITING (throwing up) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness that at times felt like she was going to faint), JOINT RANGE OF MOTION DECREASED (cannot use her left arm to do certain things), PAIN IN EXTREMITY (pain in her arm goes all the way down to her hand), VACCINATION SITE PRURITUS (itch at injection site), MYALGIA (arm is still hurting, arm hurts more while she drives, pain in her arm goes all the way down to her hand), PYREXIA (fever), VOMITING (throwing up) and HEADACHE (headache) outcome was unknown.            No concomitant medication was provided.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Very fatigued; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Very fatigued) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and VITAMINS NOS for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Very fatigued). The patient was treated with CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) at an unspecified dose and frequency. At the time of the report, FATIGUE (Very fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Vaccination site discomfort
Clinical narrative: discomfort at the injection site for a couple of days; lethargy; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE DISCOMFORT (discomfort at the injection site for a couple of days) and LETHARGY (lethargy) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (discomfort at the injection site for a couple of days) and LETHARGY (lethargy). At the time of the report, VACCINATION SITE DISCOMFORT (discomfort at the injection site for a couple of days) and LETHARGY (lethargy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Treatment information not provided.    This case was linked to MOD-2021-200328.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Body temperature, Decreased appetite, Fatigue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Slight warmth), NIGHT SWEATS (Sweating at night), PARAESTHESIA (Tingling in skin), HUNGER (feeling of hunger) and JOINT STIFFNESS (joint stiffness) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced FEELING HOT (Slight warmth), PARAESTHESIA (Tingling in skin), MYALGIA (soreness/body aches/hurt when he walked or anytime he was upright stating using a muscle or nerve was sensitive/body aches/muscle sensitivity) and PYREXIA (Fever). 03-May-2021, the patient experienced ARTHRALGIA (Joint pain) and FATIGUE (Tired/ fatigued/took everything out of him). On an unknown date, the patient experienced NIGHT SWEATS (Sweating at night), HUNGER (feeling of hunger), JOINT STIFFNESS (joint stiffness), MICTURITION DISORDER (constant feeling of needing the bathroom), DECREASED APPETITE (Loss of appetite and taste for certain foods), AGEUSIA (Loss of appetite and taste for certain foods), TEMPERATURE REGULATION DISORDER (temperature disregulation) and HEADACHE (Headache). The patient was treated with ACETAMINOPHEN for Fever, Headache, Ache, Temperature regulation disorder NOS, Joint stiffness and Fatigue, at an unspecified dose and frequency. On 12-May-2021, PARAESTHESIA (Tingling in skin), FATIGUE (Tired/ fatigued/took everything out of him), MYALGIA (soreness/body aches/hurt when he walked or anytime he was upright stating using a muscle or nerve was sensitive/body aches/muscle sensitivity) and PYREXIA (Fever) had resolved. At the time of the report, FEELING HOT (Slight warmth), HUNGER (feeling of hunger), JOINT STIFFNESS (joint stiffness), MICTURITION DISORDER (constant feeling of needing the bathroom), DECREASED APPETITE (Loss of appetite and taste for certain foods), AGEUSIA (Loss of appetite and taste for certain foods), TEMPERATURE REGULATION DISORDER (temperature disregulation), ARTHRALGIA (Joint pain) and HEADACHE (Headache) outcome was unknown and NIGHT SWEATS (Sweating at night) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4 (High) High. On an unknown date, Influenza virus test: negative (Negative) Flu A/B rapid test negative. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative by both PCR and rapid test. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-200716. Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Patient demographics added. Vaccination date added. Few events onset date and end date added. Treatment medication updated.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Hunger, Influenza virus test, Joint stiffness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Slight warmth), NIGHT SWEATS (Sweating at night), PARAESTHESIA (Tingling in skin), HUNGER (feeling of hunger) and JOINT STIFFNESS (joint stiffness) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced FEELING HOT (Slight warmth), PARAESTHESIA (Tingling in skin), MYALGIA (soreness/body aches/hurt when he walked or anytime he was upright stating using a muscle or nerve was sensitive/body aches/muscle sensitivity) and PYREXIA (Fever). 03-May-2021, the patient experienced ARTHRALGIA (Joint pain) and FATIGUE (Tired/ fatigued/took everything out of him). On an unknown date, the patient experienced NIGHT SWEATS (Sweating at night), HUNGER (feeling of hunger), JOINT STIFFNESS (joint stiffness), MICTURITION DISORDER (constant feeling of needing the bathroom), DECREASED APPETITE (Loss of appetite and taste for certain foods), AGEUSIA (Loss of appetite and taste for certain foods), TEMPERATURE REGULATION DISORDER (temperature disregulation) and HEADACHE (Headache). The patient was treated with ACETAMINOPHEN for Fever, Headache, Ache, Temperature regulation disorder NOS, Joint stiffness and Fatigue, at an unspecified dose and frequency. On 12-May-2021, PARAESTHESIA (Tingling in skin), FATIGUE (Tired/ fatigued/took everything out of him), MYALGIA (soreness/body aches/hurt when he walked or anytime he was upright stating using a muscle or nerve was sensitive/body aches/muscle sensitivity) and PYREXIA (Fever) had resolved. At the time of the report, FEELING HOT (Slight warmth), HUNGER (feeling of hunger), JOINT STIFFNESS (joint stiffness), MICTURITION DISORDER (constant feeling of needing the bathroom), DECREASED APPETITE (Loss of appetite and taste for certain foods), AGEUSIA (Loss of appetite and taste for certain foods), TEMPERATURE REGULATION DISORDER (temperature disregulation), ARTHRALGIA (Joint pain) and HEADACHE (Headache) outcome was unknown and NIGHT SWEATS (Sweating at night) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4 (High) High. On an unknown date, Influenza virus test: negative (Negative) Flu A/B rapid test negative. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative by both PCR and rapid test. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-200716. Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Patient demographics added. Vaccination date added. Few events onset date and end date added. Treatment medication updated.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Micturition disorder, Myalgia, Night sweats, Paraesthesia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Slight warmth), NIGHT SWEATS (Sweating at night), PARAESTHESIA (Tingling in skin), HUNGER (feeling of hunger) and JOINT STIFFNESS (joint stiffness) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced FEELING HOT (Slight warmth), PARAESTHESIA (Tingling in skin), MYALGIA (soreness/body aches/hurt when he walked or anytime he was upright stating using a muscle or nerve was sensitive/body aches/muscle sensitivity) and PYREXIA (Fever). 03-May-2021, the patient experienced ARTHRALGIA (Joint pain) and FATIGUE (Tired/ fatigued/took everything out of him). On an unknown date, the patient experienced NIGHT SWEATS (Sweating at night), HUNGER (feeling of hunger), JOINT STIFFNESS (joint stiffness), MICTURITION DISORDER (constant feeling of needing the bathroom), DECREASED APPETITE (Loss of appetite and taste for certain foods), AGEUSIA (Loss of appetite and taste for certain foods), TEMPERATURE REGULATION DISORDER (temperature disregulation) and HEADACHE (Headache). The patient was treated with ACETAMINOPHEN for Fever, Headache, Ache, Temperature regulation disorder NOS, Joint stiffness and Fatigue, at an unspecified dose and frequency. On 12-May-2021, PARAESTHESIA (Tingling in skin), FATIGUE (Tired/ fatigued/took everything out of him), MYALGIA (soreness/body aches/hurt when he walked or anytime he was upright stating using a muscle or nerve was sensitive/body aches/muscle sensitivity) and PYREXIA (Fever) had resolved. At the time of the report, FEELING HOT (Slight warmth), HUNGER (feeling of hunger), JOINT STIFFNESS (joint stiffness), MICTURITION DISORDER (constant feeling of needing the bathroom), DECREASED APPETITE (Loss of appetite and taste for certain foods), AGEUSIA (Loss of appetite and taste for certain foods), TEMPERATURE REGULATION DISORDER (temperature disregulation), ARTHRALGIA (Joint pain) and HEADACHE (Headache) outcome was unknown and NIGHT SWEATS (Sweating at night) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4 (High) High. On an unknown date, Influenza virus test: negative (Negative) Flu A/B rapid test negative. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative by both PCR and rapid test. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-200716. Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Patient demographics added. Vaccination date added. Few events onset date and end date added. Treatment medication updated.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Temperature regulation disorder
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Slight warmth), NIGHT SWEATS (Sweating at night), PARAESTHESIA (Tingling in skin), HUNGER (feeling of hunger) and JOINT STIFFNESS (joint stiffness) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced FEELING HOT (Slight warmth), PARAESTHESIA (Tingling in skin), MYALGIA (soreness/body aches/hurt when he walked or anytime he was upright stating using a muscle or nerve was sensitive/body aches/muscle sensitivity) and PYREXIA (Fever). 03-May-2021, the patient experienced ARTHRALGIA (Joint pain) and FATIGUE (Tired/ fatigued/took everything out of him). On an unknown date, the patient experienced NIGHT SWEATS (Sweating at night), HUNGER (feeling of hunger), JOINT STIFFNESS (joint stiffness), MICTURITION DISORDER (constant feeling of needing the bathroom), DECREASED APPETITE (Loss of appetite and taste for certain foods), AGEUSIA (Loss of appetite and taste for certain foods), TEMPERATURE REGULATION DISORDER (temperature disregulation) and HEADACHE (Headache). The patient was treated with ACETAMINOPHEN for Fever, Headache, Ache, Temperature regulation disorder NOS, Joint stiffness and Fatigue, at an unspecified dose and frequency. On 12-May-2021, PARAESTHESIA (Tingling in skin), FATIGUE (Tired/ fatigued/took everything out of him), MYALGIA (soreness/body aches/hurt when he walked or anytime he was upright stating using a muscle or nerve was sensitive/body aches/muscle sensitivity) and PYREXIA (Fever) had resolved. At the time of the report, FEELING HOT (Slight warmth), HUNGER (feeling of hunger), JOINT STIFFNESS (joint stiffness), MICTURITION DISORDER (constant feeling of needing the bathroom), DECREASED APPETITE (Loss of appetite and taste for certain foods), AGEUSIA (Loss of appetite and taste for certain foods), TEMPERATURE REGULATION DISORDER (temperature disregulation), ARTHRALGIA (Joint pain) and HEADACHE (Headache) outcome was unknown and NIGHT SWEATS (Sweating at night) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4 (High) High. On an unknown date, Influenza virus test: negative (Negative) Flu A/B rapid test negative. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative by both PCR and rapid test. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-200716. Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Patient demographics added. Vaccination date added. Few events onset date and end date added. Treatment medication updated.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 4 doses of vaccine administered more than 12 hours after puncture /vial first puncture for 4 patients was on 5/17/2021 and these 4 patients received vaccine on 5/18/2021 and 5/20/2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 doses of vaccine administered more than 12 hours after puncture /vial first puncture for 4 patients was on 5/17/2021 and these 4 patients received vaccine on 5/18/2021 and 5/20/2021) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 doses of vaccine administered more than 12 hours after puncture /vial first puncture for 4 patients was on 5/17/2021 and these 4 patients received vaccine on 5/18/2021 and 5/20/2021). On 20-May-2021, EXPIRED PRODUCT ADMINISTERED (4 doses of vaccine administered more than 12 hours after puncture /vial first puncture for 4 patients was on 5/17/2021 and these 4 patients received vaccine on 5/18/2021 and 5/20/2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   It was reported that 5 doses of COVID-19 vaccine were administered from 1 vial over a 3 day period. A vial of COVID-19 vaccine was first punctured on 17-May-2021. The vial was stored under refrigeration and subsequently used for 4 additional patients.  Two patients received doses of the vaccine on 18-May-2021 and 2 patients received doses on 20-May-2021. There were no adverse reactions. The patient's ages are 50, 67, 56 and 28 and the race of three patients is white, and one patient is black.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow-up received and reporter information and patient information updated.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: feeling a little rough; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling a little rough) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (feeling a little rough). At the time of the report, FEELING ABNORMAL (feeling a little rough) had not resolved.
Sex: U
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Leg Tingling; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Leg Tingling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Leg Tingling). At the time of the report, PARAESTHESIA (Leg Tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Parosmia
Clinical narrative: headache; body aches; change in sense of smell; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (body aches) and PAROSMIA (change in sense of smell) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced HEADACHE (headache), MYALGIA (body aches) and PAROSMIA (change in sense of smell). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 12-May-2021, HEADACHE (headache) and MYALGIA (body aches) had resolved. At the time of the report, PAROSMIA (change in sense of smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Bursal fluid accumulation, Erythema, Fatigue, Pruritus, Rash
Clinical narrative: Left arm started itching; Left arm had some fluid; Left arm was red; Had a line around her arm; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Left arm started itching), BURSAL FLUID ACCUMULATION (Left arm had some fluid), ERYTHEMA (Left arm was red), RASH (Had a line around her arm) and FATIGUE (Tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Rotator cuff injury. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), VITAMINS NOS (DAILY VITAMINS), CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) and ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, the patient experienced PRURITUS (Left arm started itching), BURSAL FLUID ACCUMULATION (Left arm had some fluid), ERYTHEMA (Left arm was red), RASH (Had a line around her arm) and FATIGUE (Tired). At the time of the report, PRURITUS (Left arm started itching), BURSAL FLUID ACCUMULATION (Left arm had some fluid), ERYTHEMA (Left arm was red), RASH (Had a line around her arm) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient states that she has a history with her left arm.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure via breast milk
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of exposure via breast milk (received 1st dose of Moderna vaccine and breastfeeding her 15-month-old daughter) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 006C21A) for COVID-19 immunization. No medical history reported. On Jun 2, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jun 2, 2021, patient experienced exposure via breast milk (received 1st dose of Moderna vaccine and breastfeeding her 15-month-old daughter). At the time of the report, exposure via breast milk (received 1st dose of Moderna vaccine and breastfeeding her 15-month-old daughter) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Sex: U
Vaccine: COVID19
Symptoms: Feeling hot, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: injection site is sore; injection site is red; hot to the touch; injection site is raised; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (injection site is sore), VACCINATION SITE ERYTHEMA (injection site is red), FEELING HOT (hot to the touch) and VACCINATION SITE SWELLING (injection site is raised) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No Adverse Events.    On 31-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced VACCINATION SITE PAIN (injection site is sore), VACCINATION SITE ERYTHEMA (injection site is red), FEELING HOT (hot to the touch) and VACCINATION SITE SWELLING (injection site is raised). At the time of the report, VACCINATION SITE PAIN (injection site is sore), VACCINATION SITE ERYTHEMA (injection site is red), FEELING HOT (hot to the touch) and VACCINATION SITE SWELLING (injection site is raised) outcome was unknown.            There is no lab data provided by the reporter.